REGIS CORPORATION

(RGS)
  Report
Delayed Nyse  -  05/20 04:00:01 pm EDT
0.8817 USD   -6.65%
05/10TRANSCRIPT : Regis Corporation, Q3 2022 Earnings Call, May 10, 2022
CI
05/10REGIS CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
05/10REGIS : Fiscal Q3 Earnings Snapshot
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Regis CEO Felipe Athayde Steps Down; Matthew Doctor Named Interim CEO

12/23/2021 | 06:54am EDT


© MT Newswires 2021
All news about REGIS CORPORATION
05/10TRANSCRIPT : Regis Corporation, Q3 2022 Earnings Call, May 10, 2022
CI
05/10REGIS CORP Management's Discussion and Analysis of Financial Condition and Results of ..
AQ
05/10REGIS : Fiscal Q3 Earnings Snapshot
AQ
05/10Earnings Flash (RGS) REGIS CORPORATION Reports Q3 Loss $-0.09
MT
05/10Earnings Flash (RGS) REGIS CORPORATION Posts Q3 Revenue $64.7M
MT
05/10Regis Corporation Reports Third Quarter 2022 Results
BU
05/05Regis Promotes Matthew Doctor to President, CEO
MT
05/05REGIS CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits ..
AQ
05/05Regis Corporation Appoints Matthew Doctor as President and Chief Executive Officer
BU
05/05Regis Corporation Appoints Matthew Doctor as President and Member of Board of Directors
CI
More news
Analyst Recommendations on REGIS CORPORATION
More recommendations
Financials (USD)
Sales 2021 415 M - -
Net income 2021 -113 M - -
Net Debt 2021 803 M - -
P/E ratio 2021 -2,97x
Yield 2021 -
Capitalization 40,1 M 40,1 M -
EV / Sales 2020 1,79x
EV / Sales 2021 2,74x
Nbr of Employees 735
Free-Float 85,9%
Chart REGIS CORPORATION
Duration : Period :
Regis Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends REGIS CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 0,88
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Matthew Doctor President, Chief Executive Officer & Director
Kersten D. Zupfer Chief Accounting Officer, VP & Controller
David J. Grissen Chairman
John Davi Chief Technology Officer & Executive VP
Jim Brian Lain Chief Operating Officer
Sector and Competitors